Marcelo M Serra, PhD is an expert in Hematology at Hospital Italiano de Buenos Aires (Argentina). As of October 2026, ScienceLeadR ranks Marcelo M Serra in the top 1% of experts worldwide for Telangiectasis, and in the top 1% of experts in Argentina for Cardiovascular Abnormalities and Hemostatic Disorders. Marcelo M Serra has authored 38 publications, the most recent in 2025, and is an investigator in 3 clinical trials, 1 of them ongoing. SLR score: 175 (community average: 125). How the SLR is computed.

LeadR Profile

Marcelo M Serra, PhD Hospital Italiano de Buenos Aires Argentina
175 ScienceLeadR Reputation 175
Network Map

Hematology

Subspecialties: Cardiology - Neurology - Pediatrics

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Short Biography

Internal Medicine specialist, head of Rare Diseases Program at Hospital Italiano de Buenos Aires, Argentina. I am passionate in vascular anomalies mainly in Hereditary Hemorrhagic Telangiectasia. I created and managing the HHT Referral Center at the same hospital. Also, I am the co-director of von Hippel Lindau Unit. I am a clinical-traslational researcher and PhD. As Rare Diseases Program director push up the best managing of complex and difficult clinical cases. I was designed Assistant Professor in the Hospital Italiano University and Associated Profesor int the Universidad de Buenos Aires, I am good at working on collaborative and multidisciplinary teams.

Organizations

Career arc: 1999 - 2025

Source: PubMed

Hospital Italiano de Buenos Aires

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 38

Citations

Citations: 445 1st author: 6 Last author: 13 Unique author: 0


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Standardization of Terminology, Definitions, and Outcome Criteria for Bleeding in Hereditary Hemorrhagic Telangiectasia: International Consensus Report.
PMID 40662351 — epistaxis, hematology, hemorrhage, anemia, telangiectasia, hereditary hemorrhagic, telangiectasis, therapeutics, iron deficiencies, angiogenesis
Am J Hematol20250
[Frequently asked questions about rare or uncommon diseases].
PMID 40793905
Medicina (B Aires)20250
Hereditary hemorrhagic telangiectasia in pediatrics: descriptive study in a specialized unit.
PMID 40762448 — epistaxis, telangiectasia, hereditary hemorrhagic, arteriovenous malformations, telangiectasis, diagnosis, therapeutics, pediatrics, child
Arch Argent Pediatr20250
Management of hereditary hemorrhagic telangiectasia-like symptoms induced by trastuzumab emtansine in a breast cancer patient: case report.
PMID 39028266 — anti-infective agents, epistaxis, vascular malformations, propranolol, breast neoplasms, neoplasms, telangiectasia, hereditary hemorrhagic, drug therapy, telangiectasis, liver, maytansine, signs and symptoms, ado-trastuzumab emtansine, pharmacology, breast, therapeutics, trastuzumab
J Chemother20240
Acute aortic dissection in a patient with Hereditary Hemorrhagic Telangiectasia associated with Juvenile Polyposis due to SMAD4 mutation: case report and literature review.
PMID 40314862 — aortic aneurysm, aneurysm, telangiectasia, hereditary hemorrhagic, telangiectasis, aortic dissection, mutation, dissection
Angiogenesis20251

Clinical Studies 3

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 1

By phase:

N/A 2
Phase 3 1

By status:

Recruiting 2
Unknown 1

By type:

Observational 2
Interventional 1

By Monocentric/Multicentric:

monocentric 2
multicentric2to4 1
multicentric5to9 0
multicentricup10 0

Main Topics

Ongoing Clinical Trials

Ongoing trial started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Institutional Registry of Rare Diseases
NCT06573723 — registries, vascular malformations, hypertension, paraganglioma, esophagitis, eosinophilic esophagitis, hypertension, pulmonary, sarcoidosis, von hippel-lindau disease, rare diseases, pheochromocytoma, immunoglobulin g4-related disease, neoplasms, angioedemas, hereditary, telangiectasia, hereditary hemorrhagic, multiple endocrine neoplasia, immunoglobulins, telangiectasis, metabolism, inborn errors, cardiomyopathy, hypertrophic, adrenal hyperplasia, congenital, amyloidosis, inflammatory bowel diseases, demyelinating diseases, mastocytosis, hepatolenticular degeneration, hyperplasia, gastrointestinal diseases, hirschsprung disease, gaucher disease, prader-willi syndrome, neurocutaneous syndromes, angioedema, cardiomyopathies, cushing syndrome
N/ARecruiting2024

LeadR Networks

Main global connection map